Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan.
Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan.
Am J Mens Health. 2021 Nov-Dec;15(6):15579883211064128. doi: 10.1177/15579883211064128.
This study investigated and compared the surgical outcomes of using endoscopic enucleation (thulium: YAG laser and bipolar plasma; ThuLEP) with robotic-assisted simple prostatectomy (RASP) in the treatment of prostates larger than 80 cm. Records were obtained for the period from January 2014 to December 2020 for selected patients with BPO who underwent RASP, ThuLEP, or bipolar transurethral enucleation of the prostate (B-TUEP). Patients were excluded if they had active malignant disease, neurogenic bladder, lower urinary tract syndrome for reasons other than BPO, and a history of prostate surgery. Data of 396 patients who underwent B-TUEP, ThuLEP, and RASP were examined. A total of 112 patients met the including criteria, 85 of whom (B-TUEP: 29; ThuLEP: 41; RASP: 15) completed the final visit. The mean operation time and duration of postoperative hospital stays in the RASP group were significantly longer than those of the B-TUEP and ThuLEP groups. Only 1 patient in the RASP group required blood transfusion. The RASP group was superior to the other groups in voiding improvement including Qmax and IPSS voiding score. The pain score of the ThuLEP group after surgery was significantly lower than that of the other two groups during hospitalization, whereas the QoL scores were identical between the three groups at 2 weeks, 3 months, and 6 months post operation. The rates of returning to ER within the first postoperative month did not differ significantly between the three groups, and all the reasons for return involved minor complications that required no additional invasive treatment. These three surgical methods (B-TUEP, ThuLEP, and RASP) are all effective and safe for treating prostates larger than 80 cm3, with each having its particular advantages. B-TUEP requires the shortest operation time, ThuLEP causes the lowest postoperative pain, and RASP results in superior voiding function improvement.
本研究调查并比较了经尿道前列腺钬激光剜除术(铥激光和双极等离子体;ThuLEP)与机器人辅助单纯前列腺切除术(RASP)治疗前列腺体积大于 80cm³的手术效果。选择了 2014 年 1 月至 2020 年 12 月期间患有 BPO 并接受 RASP、ThuLEP 或经尿道前列腺双极电切术(B-TUEP)的患者进行了记录。如果患者患有活动性恶性疾病、神经性膀胱、非 BPO 引起的下尿路综合征和前列腺手术史,则将其排除在外。共检查了 396 例接受 B-TUEP、ThuLEP 和 RASP 的患者。共有 112 例符合纳入标准,其中 85 例(B-TUEP:29 例;ThuLEP:41 例;RASP:15 例)完成了最终随访。RASP 组的手术时间和术后住院时间明显长于 B-TUEP 和 ThuLEP 组。RASP 组仅 1 例患者需要输血。在排尿改善方面,包括 Qmax 和 IPSS 排尿评分,RASP 组明显优于其他两组。ThuLEP 组术后住院期间的疼痛评分明显低于其他两组,而三组在术后 2 周、3 个月和 6 个月时的 QoL 评分相同。三组患者在术后第一个月内返回急诊室的比例无显著差异,所有返回的原因均涉及无需额外侵入性治疗的轻微并发症。这三种手术方法(B-TUEP、ThuLEP 和 RASP)对于治疗前列腺体积大于 80cm³均有效且安全,每种方法都有其特定的优点。B-TUEP 的手术时间最短,ThuLEP 的术后疼痛最低,而 RASP 的排尿功能改善效果最佳。